Showing results (2281-2290 of 3,095) with videos related to
Sort By:
Pageof 310
Clinical Kidney Journal|October 2, 2026
Novel associations of Claudin gene variants with kidney stone diseaseIris Y Liu, Jenna Haverfield, Elby MacKenzie, et al.Clinical Kidney Journal|October 2, 2026
Managing hyponatremia: fast or slow? Why, when, how, and controversiesKamel S Kamel, Ziv Harel, Martin SchreiberClinical Kidney Journal|October 7, 2026
Hypophosphatemia after CAR-T cell therapy: a prospective study of inflammation, tubular injury and phosphate handlingFrancesc Moncho-Francés, Rafael Hernani, Miguel Angel Solis-Salguero, et al.Clinical Kidney Journal|October 7, 2026
Acetate-free dialysate, protein-energy wasting, and muscle outcomes in maintenance hemodialysis: a randomized-controlled trialJulien Aniort, Solene Grall, Valerie Batel, et al.Clinical Kidney Journal|October 9, 2026
Impact of renin-angiotensin system inhibitors discontinuation in advanced chronic kidney disease: a target trial emulationValentin Maisons, Margaux Costes-Albrespic, Sophie Liabeuf, et al.Clinical Kidney Journal|October 20, 2026
Corticosteroids, serum proteins, and the next phase of precision medicine in IgA nephropathyCarmine Zoccali, Jürgen FloegeClinical Kidney Journal|October 17, 2026
New potassium binders: we need them-we do not need themLuca De Nicola, Marie Evans, Juergen Floege, et al.Clinical Kidney Journal|October 30, 2026
Preventing acute kidney injury in high-risk patientsMelanie Meersch-Dini, Michael JoannidisClinical Kidney Journal|October 30, 2026
Endothelin antagonism: a new era for resistant hypertensionGavin B Chapman, Dan Pugh, Neeraj DhaunClinical Kidney Journal|November 4, 2026
Renin-angiotensin system inhibitors initiation and mortality in non-proteinuric chronic kidney disease: a target trial emulationFan Luo, Luhua Jin, Shiyu Zhou, et al.Pageof 310